Semantic Interference and Early Detection of Dementia

语义干扰和痴呆症的早期检测

基本信息

项目摘要

DESCRIPTION (provided by applicant): The prevalence of memory disorders increases with advancing age, presenting a challenge for clinicians who must differentiate a benign condition from a serious and progressive disorder. The early diagnosis of degenerative conditions such as Alzheimer's Disease (AD) is particularly important given the continuing development of novel pharmacological agents that show promise in decreasing the rate of progression of memory impairment. Future agents will likely be most effective by limiting the extent of brain impairment when administered early in the development of the disease, making early diagnosis critical. The purpose of the proposed investigation is to assess the utility, among Hispanic and non-Hispanic elderly who are at risk for cognitive decline, of two newly developed neuropsychological tests: the Semantic Interference Test (SIT) and the Prospective Memory Test (PMT). The SIT assesses proactive and retroactive semantic interference, whereas the PMT assesses event- and time-based prospective memory. Pilot work in our laboratories using English- and Spanish-speaking elderly indicates that vulnerability to semantic interference as measured by the SIT is a more sensitive indicator of cognitive impairment in the early stages of AD than traditional neuropsychological tests that assess delayed memory or rate of forgetting. Our data also indicate that the PMT has good sensitivity and specificity in differentiating mildly impaired AD patients from normal elderly controls. A unique aspect of this study is that the predictive utility of semantic interference and prospective memory measures will be compared to traditional neuropsychological tests in predicting cognitive decline and progression to dementia among elderly Hispanic and non-Hispanic patients who are normal or who have mild cognitive impairment (MCI). Genetic risk factors such as apolipoprotein E (ApoE) status will also be assessed with regards to its ability to predict, alone and in combination with SIT and PMT measures, which individuals will develop cognitive decline and progression to dementia. The study of increased vulnerability to semantic interference and decline in prospective memory may enhance the detection of MCI and the prediction of progression to dementia in at risk populations, thus having important clinical, heuristic, and treatment implications.
描述(由申请人提供):记忆障碍的患病率随着年龄的增长而增加,这对临床医生提出了挑战,他们必须将良性疾病与严重的进行性疾病区分开来。鉴于新型药物在降低记忆障碍进展速度方面的前景不断发展,诸如阿尔茨海默病(AD)等退行性疾病的早期诊断尤为重要。未来的药物可能会通过在疾病发展的早期给药来限制脑损伤的程度,从而使早期诊断变得至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID LOEWENSTEIN其他文献

DAVID LOEWENSTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID LOEWENSTEIN', 18)}}的其他基金

A Novel Computerized Cognitive Stress Test Designed for Clinical Trials in Early Alzheimer's: Relationship with Multimodal Imaging Biomarkers in Diverse Cultural Groups
专为早期阿尔茨海默病临床试验设计的新型计算机认知压力测试:与不同文化群体中多模态成像生物标志物的关系
  • 批准号:
    10536632
  • 财政年份:
    2019
  • 资助金额:
    $ 40.48万
  • 项目类别:
A Novel Computerized Cognitive Stress Test Designed for Clinical Trials in Early Alzheimer's: Relationship with Multimodal Imaging Biomarkers in Diverse Cultural Groups
专为早期阿尔茨海默病临床试验设计的新型计算机认知压力测试:与不同文化群体中多模态成像生物标志物的关系
  • 批准号:
    10064122
  • 财政年份:
    2019
  • 资助金额:
    $ 40.48万
  • 项目类别:
A Novel Computerized Cognitive Stress Test Designed for Clinical Trials in Early Alzheimer's: Relationship with Multimodal Imaging Biomarkers in Diverse Cultural Groups
专为早期阿尔茨海默病临床试验设计的新型计算机认知压力测试:与不同文化群体中多模态成像生物标志物的关系
  • 批准号:
    10322102
  • 财政年份:
    2019
  • 资助金额:
    $ 40.48万
  • 项目类别:
Novel Detection of Early Cognitive and Functional Impairment in the Elderly
老年人早期认知和功能障碍的新检测
  • 批准号:
    8806184
  • 财政年份:
    2015
  • 资助金额:
    $ 40.48万
  • 项目类别:
Novel Detection of Early Cognitive and Functional Impairment in the Elderly
老年人早期认知和功能障碍的新检测
  • 批准号:
    9212680
  • 财政年份:
    2015
  • 资助金额:
    $ 40.48万
  • 项目类别:
Exercise Versus Cognitive Interventions for Elders at Risk for Dementia
对于有痴呆症风险的老年人来说,运动与认知干预
  • 批准号:
    7937900
  • 财政年份:
    2009
  • 资助金额:
    $ 40.48万
  • 项目类别:
Exercise Versus Cognitive Interventions for Elders at Risk for Dementia
对于有痴呆症风险的老年人来说,运动与认知干预
  • 批准号:
    7833378
  • 财政年份:
    2009
  • 资助金额:
    $ 40.48万
  • 项目类别:
COGNITIVE REHABILITATION IN ALZHEIMER'S DISEASE
阿尔茨海默病的认知康复
  • 批准号:
    6932635
  • 财政年份:
    2005
  • 资助金额:
    $ 40.48万
  • 项目类别:
Semantic Intereference and Early Detection of Dementia
语义互指和痴呆症的早期检测
  • 批准号:
    7056068
  • 财政年份:
    2003
  • 资助金额:
    $ 40.48万
  • 项目类别:
Semantic Interference and Early Detection of Dementia
语义干扰和痴呆症的早期检测
  • 批准号:
    7228075
  • 财政年份:
    2003
  • 资助金额:
    $ 40.48万
  • 项目类别:

相似国自然基金

新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 批准年份:
    2010
  • 资助金额:
    26.0 万元
  • 项目类别:
    地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
  • 批准号:
    30960334
  • 批准年份:
    2009
  • 资助金额:
    22.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Discovering early biomarkers of Alzheimer's disease using genetic and physics-informed networks
利用遗传和物理信息网络发现阿尔茨海默病的早期生物标志物
  • 批准号:
    2904538
  • 财政年份:
    2024
  • 资助金额:
    $ 40.48万
  • 项目类别:
    Studentship
Deciphering electrophysiological Alzheimer's Disease biomarkers for early diagnosis using interpretable deep learning
使用可解释的深度学习破译电生理阿尔茨海默病生物标志物以进行早期诊断
  • 批准号:
    24K18602
  • 财政年份:
    2024
  • 资助金额:
    $ 40.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
DMS/NIGMS 1: Multilevel stochastic orthogonal subspace transformations for robust machine learning with applications to biomedical data and Alzheimer's disease subtyping
DMS/NIGMS 1:多级随机正交子空间变换,用于稳健的机器学习,应用于生物医学数据和阿尔茨海默病亚型分析
  • 批准号:
    2347698
  • 财政年份:
    2024
  • 资助金额:
    $ 40.48万
  • 项目类别:
    Continuing Grant
Investigating And Targeting Microglial Senescence In Alzheimer's Disease
研究并针对阿尔茨海默病中的小胶质细胞衰老
  • 批准号:
    MR/Y004116/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.48万
  • 项目类别:
    Research Grant
Development of novel macrocyclic BACE1 inhibitors for preventive or therapeutic agents for Alzheimer's disease
开发用于预防或治疗阿尔茨海默病的新型大环 BACE1 抑制剂
  • 批准号:
    23K06058
  • 财政年份:
    2023
  • 资助金额:
    $ 40.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Incorporating Diversity in Alzheimer's Disease Research: Developing Representative and Generalizable models
将多样性纳入阿尔茨海默病研究:开发代表性和可推广的模型
  • 批准号:
    495662
  • 财政年份:
    2023
  • 资助金额:
    $ 40.48万
  • 项目类别:
    Operating Grants
Histone variant macroH2A1 as a novel regulator of memory deficits in Alzheimer's disease
组蛋白变体 MacroH2A1 作为阿尔茨海默病记忆缺陷的新型调节剂
  • 批准号:
    478226
  • 财政年份:
    2023
  • 资助金额:
    $ 40.48万
  • 项目类别:
    Operating Grants
Investigation of treatment and prevention methods for Alzheimer's disease targeting orexin neurons
针对食欲素神经元的阿尔茨海默病治疗和预防方法的研究
  • 批准号:
    23K14364
  • 财政年份:
    2023
  • 资助金额:
    $ 40.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The role of testosterone signaling in microglia: a potential role for sex differences in Alzheimer's Disease
睾酮信号在小胶质细胞中的作用:性别差异在阿尔茨海默病中的潜在作用
  • 批准号:
    23KJ1699
  • 财政年份:
    2023
  • 资助金额:
    $ 40.48万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Targeting Circadian Clock Dysfunction in Alzheimer's Disease (TClock4AD)
针对阿尔茨海默氏病的生物钟功能障碍 (TClock4AD)
  • 批准号:
    EP/X030091/1
  • 财政年份:
    2023
  • 资助金额:
    $ 40.48万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了